Medicinova (MNOV) EBITDA (2010 - 2026)
Medicinova (MNOV) posted quarterly EBITDA of -$3.1 million for Q4 2025, up 2.87% year-over-year from -$3.0 million in Q4 2024, and up 8.54% quarter-over-quarter from -$3.4 million in Q3 2025.
Medicinova (MNOV) EBITDA (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported EBITDA for 16 consecutive years, with -$3.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, EBITDA rose 2.87% year-over-year to -$3.1 million; the TTM figure through Dec 2025 stood at -$13.3 million (down 4.79% YoY), while the FY2025 annual figure was -$13.3 million, down 4.79% from the prior year.
- EBITDA climbed to -$3.1 million in Q4 2025 per MNOV's latest filing, from -$3.4 million in the prior quarter.
- Across five years, EBITDA topped out at -$201529.0 in Q1 2021 and bottomed at -$4.3 million in Q2 2021.
- Historically, EBITDA has averaged -$3.0 million across 5 years, with a median of -$3.2 million in 2022.
- Annual changes were most pronounced in 2021 — EBITDA jumped 93.11% — and 2022, when it slumped 1592.07%.
- Medicinova's EBITDA stood at -$2.1 million in 2021, then slumped by 53.66% to -$3.2 million in 2022, then gained by 22.94% to -$2.5 million in 2023, then declined by 27.85% to -$3.2 million in 2024, then climbed by 2.87% to -$3.1 million in 2025.
- Business Quant data shows MNOV's EBITDA at -$3.1 million in Q4 2025, -$3.4 million in Q3 2025, and -$3.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | -2.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.54 Mn |
| Dec 31, 2025 | -3.09 Mn |
| Sep 30, 2025 | -3.38 Mn |
| Jun 30, 2025 | -3.61 Mn |
| Mar 31, 2025 | -3.20 Mn |
| Dec 31, 2024 | -3.18 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | -3.05 Mn |
| Mar 31, 2024 | -3.14 Mn |
| Dec 31, 2023 | -2.49 Mn |
| Sep 30, 2023 | -1.15 Mn |
| Jun 30, 2023 | -3.30 Mn |
| Mar 31, 2023 | -2.96 Mn |
| Dec 31, 2022 | -3.23 Mn |
| Sep 30, 2022 | -3.90 Mn |
| Jun 30, 2022 | -4.09 Mn |
| Mar 31, 2022 | -3.41 Mn |
| Dec 31, 2021 | -2.10 Mn |
| Sep 30, 2021 | -3.60 Mn |
| Jun 30, 2021 | -4.31 Mn |